Seaward Management Limited Partnership Has Upped Merck & Co (MRK) Position By $18.69 Million; China Mobile Limited (CHL) Covered By 4 Bulls

January 16, 2018 - By Henry Gaston

Seaward Management Limited Partnership increased Merck & Co Inc (MRK) stake by 348.7% reported in 2017Q3 SEC filing. Seaward Management Limited Partnership acquired 292,033 shares as Merck & Co Inc (MRK)’s stock declined 2.46%. The Seaward Management Limited Partnership holds 375,782 shares with $24.06M value, up from 83,749 last quarter. Merck & Co Inc now has $171.61 billion valuation. The stock increased 7.38% or $4.33 during the last trading session, reaching $62.99. About 29.90M shares traded or 143.67% up from the average. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since January 16, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.

Among 6 analysts covering China Mobile (NYSE:CHL), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. China Mobile had 7 analyst reports since August 21, 2015 according to SRatingsIntel. Bernstein downgraded China Mobile Limited (NYSE:CHL) on Thursday, October 27 to “Mkt Perform” rating. The company was upgraded on Tuesday, January 19 by Deutsche Bank. The rating was initiated by Bank of America on Wednesday, August 30 with “Buy”. The firm earned “Hold” rating on Friday, March 24 by HSBC. The stock of China Mobile Limited (NYSE:CHL) has “Buy” rating given on Wednesday, August 10 by Goldman Sachs. Jefferies maintained China Mobile Limited (NYSE:CHL) rating on Friday, August 21. Jefferies has “Buy” rating and $76.13 target. See China Mobile Limited (NYSE:CHL) latest ratings:

30/08/2017 Broker: Bank of America Rating: Buy Initiate

Seaward Management Limited Partnership decreased Capital One Finl Corp Com (NYSE:COF) stake by 5,226 shares to 414,119 valued at $35.06 million in 2017Q3. It also reduced Edwards Lifesciences (NYSE:EW) stake by 4,080 shares and now owns 63,870 shares. Facebook Inc Cl A (NASDAQ:FB) was reduced too.

Investors sentiment decreased to 1.06 in Q3 2017. Its down 0.01, from 1.07 in 2017Q2. It is negative, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Hartford Investment Mgmt Company holds 0.75% or 618,987 shares in its portfolio. 12,000 are held by Summit Group Incorporated Limited Company. Moreover, Century Cos has 0.5% invested in Merck & Co., Inc. (NYSE:MRK) for 7.75 million shares. Cranbrook Wealth Mgmt Limited Liability Corp has invested 0.06% in Merck & Co., Inc. (NYSE:MRK). The Sweden-based Nordea Mngmt has invested 1.27% in Merck & Co., Inc. (NYSE:MRK). Cibc Ww Mkts owns 1.84M shares or 1.13% of their US portfolio. Plancorp Ltd Llc reported 21,838 shares stake. Girard Prns Limited invested 1.46% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Putnam Fl Invest Mgmt Co accumulated 34,602 shares. Amer Svcs Inc has 0.08% invested in Merck & Co., Inc. (NYSE:MRK). Pacific Invest Management has 24,789 shares. Wedge Mgmt L Ltd Partnership Nc accumulated 0.36% or 603,304 shares. Redmond Asset Mngmt Limited Co holds 4,805 shares or 0.14% of its portfolio. Comerica Securities owns 0.55% invested in Merck & Co., Inc. (NYSE:MRK) for 61,150 shares. Arrowmark Colorado Limited Liability Co has 0% invested in Merck & Co., Inc. (NYSE:MRK).

Among 23 analysts covering Merck & Co. Inc. (NYSE:MRK), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Merck & Co. Inc. had 71 analyst reports since August 13, 2015 according to SRatingsIntel. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Neutral” rating by Bank of America on Wednesday, January 27. On Tuesday, October 31 the stock rating was maintained by BMO Capital Markets with “Outperform”. Barclays Capital upgraded the shares of MRK in report on Tuesday, December 1 to “Overweight” rating. The firm earned “Hold” rating on Thursday, August 27 by Berenberg. The rating was upgraded by Piper Jaffray on Thursday, January 12 to “Overweight”. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Monday, October 30 by Citigroup. As per Monday, July 31, the company rating was maintained by UBS. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Buy” rating by Societe Generale on Wednesday, April 6. On Wednesday, September 30 the stock rating was initiated by Societe Generale with “Hold”. The firm has “Overweight” rating by Morgan Stanley given on Thursday, January 12.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.